Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-22

Clinical Trial Update: Dexmedetomidine Versus Morphine During Cooling Therapy in Neonates [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing dexmedetomidine versus morphine during cooling therapy in neonates with hypoxic-ischemic injury; recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Morphine (morphine)

Snippet

Sponsor: Ipsita Goswami | Conditions: Hypoxic Ischemic Brain Injury, Neonatal Encephalopathy | Phase 2 | Status: NOT_YET_RECRUITING